Maravai LifeSciences Inc.
MRVI | NASDAQ
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 208.78M | 204.73M | 185.74M | 192.28M | 215.85M | 241.86M | 259.19M | 276.92M | 278.59M | 274.1M | 288.95M | 419.52M | 543.92M | 717.73M | 883M | 906.73M | 920.28M | 895.32M | 799.24M | 669.15M | 552.2M | 381.33M |
Cost of Revenue | 136.53M | 145.36M | 152.35M | 152.17M | 153.02M | 151.67M | 150.88M | 148.54M | 148.4M | 153.4M | 148.74M | 166.89M | 168.38M | 162.6M | 168.96M | 156.34M | 150.38M | 150.7M | 142.06M | 124.82M | 112.36M | 95.74M |
Gross Profit | 72.25M | 59.37M | 33.39M | 40.11M | 62.83M | 90.19M | 108.31M | 128.38M | 130.19M | 120.7M | 140.2M | 252.63M | 375.54M | 555.13M | 714.04M | 750.4M | 769.9M | 744.63M | 657.18M | 544.33M | 439.84M | 285.59M |
Operating Income | 96.09M | 44.9M | -6.74M | -38.13M | -322.68M | -265.92M | -235.62M | -204.64M | -50.94M | -53.04M | -31.65M | 84.75M | 217.07M | 409.38M | 574.22M | 616.06M | 654.53M | 627.37M | 551.19M | 431.35M | 321.69M | 176.28M |
Interest Income | 20.72M | 22.59M | 23.95M | 27.6M | 19.36M | 23.42M | 27.4M | 28.83M | 29.19M | 28.89M | 27.73M | 22.61M | 15.17M | 8.38M | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -136.49M | -188.81M | -234.97M | -218.47M | -348.96M | -291.76M | -261.48M | 441.21M | 596.29M | 599.85M | 617.74M | 57.43M | 191.75M | 380.11M | 551.47M | 599.42M | 636.67M | 607.57M | 529.9M | 400.92M | 288.56M | 143.36M |
Net Income | -77.39M | -104.56M | -130.77M | -121.24M | -194.72M | -162.71M | -144.85M | -224.66M | -132.08M | -131.04M | -119.03M | 24.56M | 75.5M | 153.28M | 220.21M | 238.01M | 247.51M | 225.41M | 181.65M | 139.33M | 124.32M | 75.39M |
Selling & General & Admin | 154.49M | 159.24M | 171.47M | 197.52M | 158.47M | 160.45M | 161.77M | 159.01M | 158.78M | 153.6M | 151.39M | 150.12M | 142.05M | 134.73M | 129.26M | 119.61M | 115.33M | 111.77M | 102.04M | 116.1M | 110.1M | 101.59M |
Research & Development | 21.15M | 22.33M | 23.33M | 24.1M | 18.68M | 19.08M | 19.22M | 19.25M | 19.26M | 18.17M | 17.28M | 17.7M | 18.74M | 18.82M | 18.37M | 22.53M | 19.09M | 16.74M | 15.21M | 8.13M | 8.05M | 7.72M |
Other Expenses | -199.45M | -167.11M | -154.67M | -143.38M | 208.37M | 176.58M | 162.93M | 154.76M | 3.09M | 1.97M | 3.18M | 69K | -2.32M | -7.8M | -7.8M | -7.8M | -19.05M | -11.25M | -11.25M | -11.25M | n/a | n/a |
Operating Expenses | -23.81M | 14.47M | 40.13M | 78.24M | 385.51M | 356.11M | 343.93M | 333.02M | 181.13M | 173.74M | 171.85M | 167.88M | 158.47M | 145.75M | 139.83M | 134.34M | 115.37M | 117.26M | 106M | 112.98M | 118.15M | 109.31M |
Interest Expense | 2.84M | 25.96M | 26.99M | 31.7M | 38.49M | 43.61M | 47.7M | 51.84M | 49.84M | 44.92M | 45.89M | 40.67M | 32.17M | 29.58M | 20.41M | 14.67M | 19.22M | 22.43M | 27.67M | 32.04M | 31.45M | 31.26M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 112.72M | 159.83M | 192.48M | 230.41M | 538.54M | 507.77M | 494.8M | 481.56M | 329.53M | 327.14M | 320.59M | 334.77M | 326.85M | 308.35M | 308.79M | 290.68M | 265.75M | 267.96M | 248.05M | 237.8M | 230.51M | 205.05M |
Income Tax Expense | -12.27M | -4.53M | -4.21M | -4.23M | -3.82M | -1.97M | -1.86M | 764.32M | 758.54M | 759.56M | 756.11M | -1.61M | 17.96M | 37.65M | 60.81M | 69.94M | 74.67M | 67.79M | 61.52M | 44.31M | 25.11M | 12.95M |
Shares Outstanding (Basic) | 147.22M | 146.43M | 145.07M | 144.68M | 144.24M | 143.43M | 141.81M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.63M | 131.54M | 131.5M | 131.5M | 131.46M | 118.43M | 112.2M | 96.65M |
Shares Outstanding (Diluted) | 147.22M | 146.43M | 145.07M | 144.68M | 144.24M | 143.43M | 139.73M | 141.56M | 135.84M | 132.33M | 132.14M | 131.93M | 131.86M | 131.74M | 131.65M | 131.65M | 121.97M | 121.97M | 121.97M | 121.97M | 112.28M | 96.67M |
EPS (Basic) | -0.54 | -0.73 | -0.91 | -0.84 | -1.36 | -1.15 | -1.03 | -1.65 | -1 | -0.99 | -0.91 | 0.55 | 1.36 | 2.60 | 3.73 | 3.49 | 3.19 | 2.44 | 1.56 | 1.40 | 1.38 | 0.94 |
EPS (Diluted) | -0.54 | -0.73 | -0.91 | -0.84 | -1.36 | -1.15 | -1.03 | -1.65 | -1 | -0.99 | -0.91 | 0.55 | 1.36 | 2.69 | 3.90 | 3.66 | 3.34 | 2.50 | 1.54 | 1.34 | 1.34 | 0.90 |
EBITDA | -67.07M | -103.91M | -147.11M | -126.1M | -251.61M | -190.13M | -156.92M | 548.36M | 700.5M | 696.4M | 712.41M | 143.93M | 266.57M | 449.45M | 609.99M | 645.6M | 685.5M | 660.86M | 585.48M | 463.35M | 349.07M | 199.99M |
EBIT | -95.54M | -162.85M | -207.98M | -186.77M | -310.47M | -248.15M | -213.78M | 493.04M | 646.13M | 644.77M | 663.63M | 98.1M | 223.92M | 409.69M | 571.89M | 614.09M | 655.89M | 630M | 557.57M | 432.96M | 320.01M | 174.62M |
Depreciation & Amortization | 30.58M | 58.94M | 60.87M | 60.66M | 58.86M | 58.02M | 56.87M | 55.32M | 54.38M | 51.63M | 48.78M | 45.83M | 42.64M | 39.75M | 38.1M | 31.52M | 29.61M | 30.87M | 27.91M | 30.39M | 29.06M | 25.37M |
Add to Watchlist
Select watchlists to add or remove MRVI